Literature DB >> 10346936

Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.

T Sakai1, O V Naidenko, H Iijima, M Kronenberg, Y Koezuka.   

Abstract

A representative alpha-galactosylceramide (alpha-GalCer), KRN7000, has strong immunostimulatory and antitumor activity. Recent studies demonstrated that KRN7000-pulsed antigen-presenting cells (APC) can activate natural killer T (NKT) cells, a novel T-cell lineage, and CD1d molecules on APC play an important role in the activation of NKT cells. However, it remains unclear whether alpha-GalCers actually bind to CD1d molecules. To address this question, we synthesized three kinds of biotinylated alpha-GalCer and a biotinylated beta-GalCer and found that the biotinylated alpha-GalCers significantly stimulate the proliferation of murine spleen cells, but the biotinylated beta-GalCer does not and that all biotinylated compounds bind to CD1d molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346936     DOI: 10.1021/jm990054n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

Review 1.  Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Neal N Padte; Xiangming Li; Moriya Tsuji; Sandhya Vasan
Journal:  Clin Immunol       Date:  2010-12-24       Impact factor: 3.969

2.  Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses.

Authors:  Marcus Niemeyer; Alexandre Darmoise; Hans-Joachim Mollenkopf; Karin Hahnke; Robert Hurwitz; Gurdyal S Besra; Ulrich E Schaible; Stefan H E Kaufmann
Journal:  Immunology       Date:  2007-10-04       Impact factor: 7.397

3.  Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.

Authors:  Rafael S Grajewski; Anna M Hansen; Rajeev K Agarwal; Mitchell Kronenberg; Stephane Sidobre; Shao Bo Su; Phyllis B Silver; Moriya Tsuji; Richard W Franck; Anne P Lawton; Chi-Chao Chan; Rachel R Caspi
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria.

Authors:  G Gonzalez-Aseguinolaza; C de Oliveira; M Tomaska; S Hong; O Bruna-Romero; T Nakayama; M Taniguchi; A Bendelac; L Van Kaer; Y Koezuka; M Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Structural requirements for antigen presentation by mouse CD1.

Authors:  N Burdin; L Brossay; M Degano; H Iijima; M Gui; I A Wilson; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 6.  Interplay between carbohydrate and lipid in recognition of glycolipid antigens by natural killer T cells.

Authors:  Bo Pei; Jose Luis Vela; Dirk Zajonc; Mitchell Kronenberg
Journal:  Ann N Y Acad Sci       Date:  2012-02-21       Impact factor: 5.691

7.  Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules.

Authors:  O V Naidenko; J K Maher; W A Ernst; T Sakai; R L Modlin; M Kronenberg
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

8.  Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.

Authors:  Peter J Jervis; Paolo Polzella; Justyna Wojno; John-Paul Jukes; Hemza Ghadbane; Yoel R Garcia Diaz; Gurdyal S Besra; Vincenzo Cerundolo; Liam R Cox
Journal:  Bioconjug Chem       Date:  2013-03-19       Impact factor: 4.774

Review 9.  Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.

Authors:  Susannah C Shissler; Michael S Lee; Tonya J Webb
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.